A detailed history of Integral Health Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 50,000 shares of BNTX stock, worth $4.99 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$4.99 Million
% of portfolio
0.7%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$78.36 - $124.66 $3.92 Million - $6.23 Million
50,000 New
50,000 $5.94 Million
Q2 2023

Aug 11, 2023

BUY
$102.58 - $129.66 $3.69 Million - $4.67 Million
36,000 New
36,000 $3.89 Million
Q3 2021

Nov 12, 2021

SELL
$205.93 - $447.23 $3.5 Million - $7.6 Million
-17,000 Closed
0 $0
Q2 2021

Aug 30, 2021

SELL
$113.32 - $241.49 $1.93 Million - $4.11 Million
-17,000 Reduced 50.0%
17,000 $3.81 Million
Q2 2021

Aug 13, 2021

BUY
$113.32 - $241.49 $3.85 Million - $8.21 Million
34,000 New
34,000 $7.61 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.